09:01 AM EDT, 07/28/2025 (MT Newswires) -- US equity futures posted narrow gains ahead of Monday's opening bell, with investor sentiment buoyed by weekend media reports that the US and EU have struck a trade deal.

Dow Jones Industrial Average futures were 0.1% higher, S&P 500 futures were up 0.2%, and Nasdaq futures were 0.4% higher.

The trade deal includes a 15% tariff on most imports from the EU, including automobiles, media outlets reported.

Oil prices were higher, with front-month global benchmark North Sea Brent crude up 1.9% at $68.93 per barrel and US West Texas Intermediate crude 2% higher at $66.43 per barrel.

The July Dallas Fed Manufacturing Survey is due for release at 10:30 am ET.

In other world markets, Japan's Nikkei closed 1.1% lower, Hong Kong's Hang Seng ended 0.7% higher, and China's Shanghai Composite finished 0.1% higher. Meanwhile, the UK's FTSE 100 was down 0.3%, and Germany's DAX index was also 0.3% lower in Europe's early afternoon session.

In equities, Celcuity ( CELC ) stock was up more than 200% pre-bell after the company said results from a phase 3 trial showed that a combination of gedatolisib, palbociclib, and fulvestrant reduced the risk of disease progression or death by 76% compared with fulvestrant alone in patients with locally advanced or metastatic breast cancer.

On the losing side, ATAI Life Sciences ( ATAI ) shares were 11% lower after the company said Friday that its phase 2b trial of inidascamine in patients with cognitive impairment associated with schizophrenia failed to achieve its primary endpoint.